Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting

Our data support the idea that direct injection of aBM-MNCs in the myocardium during CABG is feasible and safe. Larger studies are needed to assess the efficacy of such an approach in patients undergoing CABG.